Literature DB >> 31284922

Early Life Respiratory Syncytial Virus Infection and Asthmatic Responses.

Catherine Ptaschinski1, Nicholas W Lukacs2.   

Abstract

The infant's developing immune response is central to establishing a balanced system that reacts appropriately to infectious stimuli, but does not induce altered disease states with potential long-term sequelae. Respiratory syncytial virus may alter the immune system, affecting future responses. Early infection may have direct effects on the lung itself. Other early life processes contribute to the development of immune responses including assembly of the microbiome, which seems to have a particularly important role for establishing the immune environment. This review covers studies that have set up important paradigms and discusses recent data that direct research toward informative hypotheses.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma; Neonatal; RSV; Th2; Viral infections

Mesh:

Year:  2019        PMID: 31284922     DOI: 10.1016/j.iac.2019.03.002

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  4 in total

1.  Master manipulators: how herpesviruses alter immune responses to RSV.

Authors:  Stephen J Gurczynski; Bethany B Moore
Journal:  Mucosal Immunol       Date:  2020-06-11       Impact factor: 7.313

Review 2.  Role of Mitochondria in Viral Infections.

Authors:  Srikanth Elesela; Nicholas W Lukacs
Journal:  Life (Basel)       Date:  2021-03-11

3.  Molecular Mechanism of Jinchan Oral Liquid in the Treatment of Children with Respiratory Syncytial Virus Pneumonia Based on Network Pharmacology and Molecular Docking Technology.

Authors:  Li Shen; Yiguo Jiang; Jinmiao Lu; Guangfei Wang; Xiaolan Zhang; Sumei He; Cheng Wang; Zhiping Li
Journal:  Biomed Res Int       Date:  2021-08-26       Impact factor: 3.411

Review 4.  Targeting the Pulmonary Microbiota to Fight against Respiratory Diseases.

Authors:  Zongjie Li; Yuhao Li; Qing Sun; Jianchao Wei; Beibei Li; Yafeng Qiu; Ke Liu; Donghua Shao; Zhiyong Ma
Journal:  Cells       Date:  2022-03-07       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.